Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Institut Curie
Gustave Roussy, Cancer Campus, Grand Paris
Gustave Roussy, Cancer Campus, Grand Paris
Centre Oscar Lambret
Children's Hospital of Philadelphia
DL Analytics
Elephas
Brigham and Women's Hospital
Centre Antoine Lacassagne
Emory University
Centre Hospitalier Universitaire de Nice
University of Manchester
M.D. Anderson Cancer Center
Herlev and Gentofte Hospital
University of Arizona
National Cancer Institute (NCI)
Ardigen
University of New Mexico
Elsan
Hoffmann-La Roche
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Ardigen
RenJi Hospital
AdventHealth
Yale University
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
University of Sao Paulo